Showing 201 - 220 results of 668 for search '"inflammatory bowel disease"', query time: 0.12s Refine Results
  1. 201
  2. 202
  3. 203

    Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease by Qingquan Chen, Shirong Huang, Yue Wu, Shuyu Zhang, Qicai Liu, Min Chen

    Published 2021-01-01
    “…Inflammatory bowel disease (IBD) is a group of immune-mediated conditions. …”
    Get full text
    Article
  4. 204

    The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis. by Kelly A Baker, Timothy D Miller, Frank E Marino, Tegan E Hartmann

    Published 2022-01-01
    “…<h4>Background</h4>This study investigated selected inflammatory responses to acute and chronic exercise in individuals with inflammatory bowel disease (IBD).<h4>Methods</h4>A systematic review and meta-analysis was conducted on all relevant exercise-based intervention publications with IBD participants. …”
    Get full text
    Article
  5. 205

    A Rare Form of Chronic Granulomatous Disease (Type Iva) Presenting as Inflammatory Bowel Disease by Francisco A Sylvester

    Published 1996-01-01
    “…Therefore it should be considered in the differential diagnosis of atypical inflammatory bowel disease, both in children and young adults.…”
    Get full text
    Article
  6. 206

    Depletion of key gut bacteria predicts disrupted bile acid metabolism in inflammatory bowel disease by Daniel Peterson, Christopher Weidenmaier, Sonia Timberlake, Rotem Gura Sadovsky

    Published 2025-02-01
    “…In particular, Inflammatory Bowel Disease (IBD) is characterized by a low concentration of secondary bile acids (SBAs), whose transformation from primary bile acids (PBAs) is an essential function performed solely by gut bacteria. …”
    Get full text
    Article
  7. 207

    Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs by Anna Pau, Ilaria Galliano, Elisa Barnini, Maddalena Dini, Antonio Pizzol, Alice Ponte, Stefano Gambarino, Pier Luigi Calvo, Massimiliano Bergallo

    Published 2025-01-01
    “…<i>Background</i>: Over the past decade, TNF inhibitors such as Infliximab and Adalimumab have become central to Inflammatory Bowel Diseases treatment, greatly enhancing patient outcomes. …”
    Get full text
    Article
  8. 208

    Differential pathological changes in colon microenvironments in acute and chronic mouse models of inflammatory bowel disease by NaYeon Ham, Minji Park, Young-An Bae, Eui-Ju Yeo, YunJae Jung

    Published 2025-12-01
    “…Inflammatory bowel disease is a chronic condition characterized by inflammation of the gastrointestinal tract, resulting from an abnormal immune response to normal stimuli, such as food and intestinal flora. …”
    Get full text
    Article
  9. 209

    Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year by Lars-Petter Jelsness-Jørgensen, Bjørn Moum, Tomm Bernklev

    Published 2011-01-01
    “…Disease-related worries are frequently reported in inflammatory bowel disease (IBD), but longitudinal assessments of these worries are scarce. …”
    Get full text
    Article
  10. 210

    Are there also negative effects of social support? A qualitative study of patients with inflammatory bowel disease by Alexander Palant, Wolfgang Himmel

    Published 2019-01-01
    “…By conducting a series of interviews with people who suffer from inflammatory bowel disease (IBD), we received the impression that social support in face-to-face or online communication could also be a source of stress and strain. …”
    Get full text
    Article
  11. 211

    Clinicians’ Guide to the Use of Fecal Calprotectin to Identify and Monitor Disease Activity in Inflammatory Bowel Disease by Brian Bressler, Remo Panaccione, Richard N Fedorak, Ernest G Seidman

    Published 2015-01-01
    “…BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. …”
    Get full text
    Article
  12. 212

    The Challenges of Living with Inflammatory Bowel Disease: Summary of a Summit on Patient and Healthcare Provider Perspectives by Judith Bray, Aida Fernandes, Geoffrey C. Nguyen, Anthony R. Otley, Joan Heatherington, Jennifer Stretton, Natasha Bollegala, Eric I. Benchimol

    Published 2016-01-01
    “…Canada has one of the highest rates of inflammatory bowel disease (IBD) and the disease represents a significant health, social, and economic burden. …”
    Get full text
    Article
  13. 213

    Natural Killer Cell and Large Granular Lymphocyte Deficiency in the Gut of Children with Inflammatory Bowel Disease by F Hadziselimovic, LR Emmons, U Schaub

    Published 1990-01-01
    “…The occurrence of natural killer cells and large granular lymphocytes (LGL) within the epithelium of colonic mucosa in children with inflammatory bowel disease (IBD) was compared to normal controls. …”
    Get full text
    Article
  14. 214
  15. 215
  16. 216
  17. 217
  18. 218

    Bone Loss Prevention of Bisphosphonates in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis by Yan Hu, Xiaoting Chen, Xiaojing Chen, Shuang Zhang, Tianyan Jiang, Jing Chang, Yanhong Gao

    Published 2017-01-01
    “…The purpose of this study was to evaluate the effect of bisphosphonates in improving bone mineral density (BMD) and decreasing the occurrence rate of fractures and adverse events in patients with inflammatory bowel disease (IBD). Methods. Randomized controlled trials (RCTs) which use bisphosphonates in IBD patients were identified in PubMed, MEDLINE database, EMBASE database, Web of Knowledge, and the Cochrane Databases between 1990 and June 2016. …”
    Get full text
    Article
  19. 219
  20. 220